Estimates were made for Canada, Mexico, the United States of America and 20 Caribbean countries and territories in the IDF North America and Caribbean (NAC) Region. Estimates for diabetes in adults in the Region were taken from 26 data sources, representing 17 of the 23 countries. Barbados, Canada, Haiti and United Stats of America had studies conducted within the past five years.
NAC Region has the second highest diabetes prevalence among IDF Regions at 14%. IDF projects that the number of people with diabetes in NAC Region will increase 24% reaching 63 million by 2045. The NAC Region has the second highest number of children and adolescents with type 1 diabetes - 193,000 in total. The NAC Region has second highest mortality due to diabetes (931,000) and the second highest percentage (18,4%) of diabetes-related deaths in people of working age among IDF Regions. The NAC Region has the highest diabetes-related expenditure (USD 415 billion) associated with diabetes, 43% of global expenditure. The NAC Region has the highest average cost per person with diabetes (20-79y) - USD 8,208.
| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 21,375.1 | 37,700.0 | 50,547.0 | 57,000.0 | 63,000.0 |
| Age-adjusted comparative prevalence of diabetes, % | 7.8 | 10.7 | 11.9 | 13.3 | 14.2 |
| People with undiagnosed diabetes, in 1,000s | - | - | 12,224.9 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 24.2 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 36,900.0 | 46,988.5 | 51,800.0 | 56,600.0 |
| Age-adjusted comparative prevalence of IGT, % | - | 10.7 | 11.2 | 11.5 | 11.7 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 31,637.3 | 34,200.0 | 37,600.0 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 8.3 | 8.6 | 8.7 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 280,800.0 | 930,692.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 11.4 | 14.6 | 18.7 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 24.4 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 67.4 | 94.7 | 98.2 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 192.5 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 1,330,944.5 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 20.7 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 59,521.6 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 167,148.9 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | 223,500.0 | 414,509.2 | 404,715.8 | 408,700.0 |
| Total diabetes-related health expenditure, ID million | - | - | 436,713.0 | 406,069.6 | 410,190.3 |
| Diabetes-related health expenditure per person, USD | - | 1,928.4 | 8,208.9 | 1,767.9 | 1,696.9 |
| Diabetes-related health expenditure per person, ID | - | - | 8,648.6 | 2,284.1 | 2,198.1 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 273,800.0 | 322,000.0 | 361,387.9 | 387,594.2 | 413,000.0 |
| Population of children (0-14 y), in 1,000s | 109,010.0 | - | 105,462.1 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 141,783.2 | - | - |